1. Home
  2. CLLS vs HUSA Comparison

CLLS vs HUSA Comparison

Compare CLLS & HUSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • HUSA
  • Stock Information
  • Founded
  • CLLS 1999
  • HUSA N/A
  • Country
  • CLLS France
  • HUSA United States
  • Employees
  • CLLS N/A
  • HUSA N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • HUSA Oil & Gas Production
  • Sector
  • CLLS Health Care
  • HUSA Energy
  • Exchange
  • CLLS Nasdaq
  • HUSA Nasdaq
  • Market Cap
  • CLLS 299.0M
  • HUSA 339.8M
  • IPO Year
  • CLLS 2007
  • HUSA N/A
  • Fundamental
  • Price
  • CLLS $3.79
  • HUSA $6.22
  • Analyst Decision
  • CLLS Buy
  • HUSA
  • Analyst Count
  • CLLS 1
  • HUSA 0
  • Target Price
  • CLLS $4.00
  • HUSA N/A
  • AVG Volume (30 Days)
  • CLLS 151.7K
  • HUSA 209.6K
  • Earning Date
  • CLLS 11-03-2025
  • HUSA 11-13-2025
  • Dividend Yield
  • CLLS N/A
  • HUSA N/A
  • EPS Growth
  • CLLS N/A
  • HUSA N/A
  • EPS
  • CLLS N/A
  • HUSA N/A
  • Revenue
  • CLLS $63,438,000.00
  • HUSA N/A
  • Revenue This Year
  • CLLS N/A
  • HUSA N/A
  • Revenue Next Year
  • CLLS $66.76
  • HUSA N/A
  • P/E Ratio
  • CLLS N/A
  • HUSA N/A
  • Revenue Growth
  • CLLS 223.09
  • HUSA N/A
  • 52 Week Low
  • CLLS $1.10
  • HUSA $3.85
  • 52 Week High
  • CLLS $3.83
  • HUSA $32.00
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 65.98
  • HUSA 33.34
  • Support Level
  • CLLS $3.36
  • HUSA $6.10
  • Resistance Level
  • CLLS $3.60
  • HUSA $6.77
  • Average True Range (ATR)
  • CLLS 0.24
  • HUSA 0.41
  • MACD
  • CLLS 0.02
  • HUSA 0.08
  • Stochastic Oscillator
  • CLLS 96.95
  • HUSA 11.02

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

About HUSA Houston American Energy Corporation

Houston American Energy Corp is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its properties, and operations, are in the U.S. Permian Basin, the U.S. Gulf Coast region, particularly Louisiana, and the South American country of Colombia. Geographically, the company currently has operations in two geographical areas, the United States, from where it derives maximum revenue, and Colombia.

Share on Social Networks: